Metoprolol Succinate Tablet, Film Coated, Extended Release
Product Images NDC 55111-469

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 55111-469). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton3 (Carton3)

Metoprolol Succinate Extended-Release Tablets USP, 100 mg carton label for 100 tablets (10 x 10 unit-dose) by Dr. Reddy's Laboratories Limited. The label indicates Rx only and storage instructions, with a barcode and manufacturer information. The product is an extended-release tablet form, labeled for prescription use.*

FDA Label Image

Carton4 (Carton4)

Packaging label for Metoprolol Succinate Extended-Release Tablets USP, 200 mg, manufactured by Dr. Reddy's Laboratories Limited. The label indicates a package containing 100 tablets (10 x 10 unit-dose). It includes dosage, storage instructions, and warnings. The label design features the product name in blue and green text with the Dr. Reddy's logo.*

FDA Label Image

Container3 (Container3)

Label for Metoprolol Succinate Extended-Release Tablets USP, 100 mg, a tablet in extended-release form supplied by Dr. Reddy's Laboratories Limited. The label specifies 100 tablets per bottle and includes storage, expiration, and warning information along with a barcode.*

FDA Label Image

Container4 (Container4)

Packaging label for Metoprolol Succinate Extended-Release Tablets USP, 200 mg, featuring a 100-count bottle. The label states the product is Rx Only and includes manufacturer information: Dr. Reddy's Laboratories Limited, located in India. The label details that each film-coated tablet contains 190 mg metoprolol succinate equivalent to 200 mg metoprolol base.*

FDA Label Image

Figure (Figure)

A forest plot titled 'Results for Subgroups in MERIT-HF,' showing relative risk and 95% confidence intervals across different subgroups for outcomes: total mortality, total mortality or all-cause hospitalization, and total mortality or hospitalization for heart failure. The chart compares metoprolol succinate extended-release tablets versus placebo, including subgroups by clinical characteristics such as NYHA class, ejection fraction, ischemic etiology, sex, race, diabetes, hypertension, and heart rate.*

FDA Label Image

Structure (Structure)

Chemical structure of metoprolol succinate showing the molecular arrangement of metoprolol linked to succinate groups, as depicted by the formulas and bonded atoms in the image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.